The combinations with stronger binding interactions were AKT1 and luteolin, AKT1 and quercetin, and SRC and quercetin, with −9.9, −9.8, and −9.2 kcal/mol, respectively, indicating that these active components have strong binding affinity for their targets and may play an important role in the treatment of VD by GBLs. This evidence concerns the gene AKT1 and sexually transmitted disease.